1. Search Result

Search Result

Results for "849776-05-2" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-19519

    DF 2156A free base

    CXCR Cancer Inflammation/Immunology
    Ladarixin (DF 2156A) is an orally available, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin (DF 2156A) is used in the study for COPD and asthma study.